Navigation Links
Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
Date:3/16/2009

BRIDGEWATER, N.J., March 16 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today that Paul Chew, M.D., has been appointed to Chief Science Officer/Chief Medical Officer, U.S., effective April 1. He was previously President, R&D, sanofi-aventis, U.S.

As the company's Chief Science Officer and Chief Medical Officer, Paul Chew will establish a unified medical voice for sanofi-aventis U.S. among internal and external stakeholders. He will be responsible for overseeing U.S. Medical Affairs in addition to his continued oversight of the U.S. R&D organization in coordination with the Group in Paris. Further, Paul Chew will be charged with representing accurate and timely clinical and safety information to health authorities, payers, patients and physicians that will foster safe and appropriate use of our products.

Paul Chew's primary reporting will be to Greg Irace, President and Chief Executive Officer, sanofi-aventis U.S., in addition to Marc Cluzel, Group Senior Vice President of R&D and Jean-Pierre Lehner, Group Chief Medical Officer.

"Paul brings deep, scientific expertise and proven leadership to both the R&D and Medical functions in the U.S. - a critical area in which the science and the business of our industry intersect," said Greg Irace. "In this new role, Paul will be in a position to bring greater scientific and product insights to our organization, greater clarity and dialogue with members of the healthcare system and, ultimately, greater value to patients in the form of improved health outcomes."

The new role of Chief Science Officer/Chief Medical Officer is part of the company's overall organizational drive to ensure all components of the U.S. affiliate work in a coordinated manner to achieve harmonized processes, cost-effectiveness and best practice sharing in the design, conduct and monitoring of clinical studies.

About sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

For more information, www.sanofi-aventis.us or www.sanofi-aventis.com

    Media Contact:

    Lisa Buffington
    908-981-6569
    Lisa.Buffington@sanofi-aventis.com


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Jim Yong Kim Appointed 17th President of Dartmouth College
2. Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. Brickson Diamond Appointed Board Chair of National Hospice Foundation
5. Valensa Internationals Dr. Rudi E. Moerck Appointed CEO
6. Margaret Laub Appointed to IntelliDOT Board of Directors
7. Laurence Debroux Appointed Chief Strategic Officer (CSO)
8. Jean-Pierre Lehner Appointed Chief Medical Officer
9. Alice Stollenwerk Petrulis, MD, FACP, Appointed to NQF Care Coordination Committee
10. Former Assistant Secretary for Aging, The Honorable Josefina G. Carbonell, Appointed Senior Vice President at Independent Living Systems
11. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Fillers are known for building youthful ... that popular cosmetic fillers can enhance earlobes and rejuvenate an aging ... the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. “People often ...
(Date:1/18/2017)... Baltimore, MD (PRWEB) , ... January 18, 2017 ... ... University of Maryland Fischell Department of Bioengineering are collaborating on a research project ... professor in bioengineering, the project seeks to use nanotechnology to control the disease ...
(Date:1/18/2017)... ... January 18, 2017 , ... PrideStaff, a national, ... Franchise Development, Paula Turner Pizarro, was recently featured on Fox Business Network's Worldwide ... of top business leaders from across the globe, provides viewers an opportunity to ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... be presenting at the upcoming WCBP Conference, to be held at the Mayflower ...
(Date:1/18/2017)... , ... January 18, 2017 , ... Floundering on New ... Month and the perfect time for a reset. The U.S. Apple Association agrees and ... combat many of the factors that contribute to heart disease. , The U.S. Apple ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... and PUNE, India , January 18, ... Allied Market Research, titled, "Breast Imaging Technologies Market by Type: ... global breast imaging technologies market size was valued at $2,544 ... by 2022, growing at a CAGR of 8.4% from 2016 ... Europe together accounted for over three-fourths market ...
(Date:1/18/2017)... 2017   Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies to ... reported the Company,s operating results for 2016 and an ... the Company described in its recent 10-K filing with ... accomplishments. The Company,s contract laboratory completed its evaluation of ...
(Date:1/18/2017)... DAVOS , Suiza, 18 de enero de 2017 ... biofarmacéuticas líderes lanzaron Access Accelerated, una iniciativa global para ... comunicables (NCD) y atención en países de renta baja ... NCD han alcanzado un punto de crisis, particularmente en ... casi el 80 por ciento de las muertes relacionadas ...
Breaking Medicine Technology: